Published in N Engl J Med on July 10, 2014
Renal denervation for resistant hypertension. N Engl J Med (2014) 0.81
Neuropeptide Y as an indicator of successful alterations in sympathetic nervous activity after renal sympathetic denervation. Clin Res Cardiol (2015) 0.76
A controlled trial of renal denervation for resistant hypertension. N Engl J Med (2014) 14.22
Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J Hypertens (2012) 3.73
Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension (2007) 2.90
Short- and long-term incidence of stroke in white-coat hypertension. Hypertension (2004) 2.58
Ambulatory arterial stiffness index: merits and limitations of a simple surrogate measure of arterial compliance. J Hypertens (2008) 1.66
Heritability of central blood pressure and arterial stiffness: a twin study. J Hypertens (2012) 1.45
Prognostic value of serial electrocardiographic voltage and repolarization changes in essential hypertension: the HEART Survey study. Am J Hypertens (2007) 1.43
Pressure-independent relationship of aortic characteristic impedance with left ventricular mass and geometry in untreated hypertension. J Hypertens (2015) 1.43
Decreasing cardiovascular risk in HIV infection between 2005 and 2011. AIDS (2014) 1.39
Are observational studies more informative than randomized controlled trials in hypertension? Con side of the argument. Hypertension (2013) 1.38
CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation (2004) 1.36
Evaluation of the Vicorder, a novel cuff-based device for the noninvasive estimation of central blood pressure. J Hypertens (2013) 1.36
Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol (2006) 1.36
Precocious intima-media thickening in patients with primary Sjögren's syndrome. Arthritis Rheum (2005) 1.25
Diagnostic performance of a multiple real-time PCR assay in patients with suspected sepsis hospitalized in an internal medicine ward. J Clin Microbiol (2012) 1.19
The first statement of the Working Group on Electrocardiographic Diagnosis of Left Ventricular Hypertrophy. J Electrocardiol (2010) 1.12
Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients. J Hypertens (2007) 1.10
Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension. Hypertens Res (2008) 1.05
Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media. Ann N Y Acad Sci (2005) 1.01
Identifying HIV patients with an unfavorable cardiovascular risk profile in the clinical practice: results from the SIMONE study. J Infect (2008) 1.00
Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk. Atherosclerosis (2007) 0.97
Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects. J Am Coll Cardiol (2002) 0.97
Left radial versus right radial approach for coronary artery catheterization: a prospective comparison. J Interv Cardiol (2012) 0.97
Is estimated cardiovascular risk higher in HIV-infected patients than in the general population? Scand J Infect Dis (2007) 0.95
Functional impairment of the arterial wall in primary Sjögren's syndrome: combined action of immunologic and inflammatory factors. Arthritis Care Res (Hoboken) (2010) 0.94
Paraoxonase-1 activity modulates endothelial function in patients with peripheral arterial disease. Atherosclerosis (2005) 0.90
Capillary rarefaction and abnormal cardiovascular reactivity in hypertension. J Hypertens (2003) 0.90
Effects of rosuvastatin on 3-nitrotyrosine and aortic stiffness in hypercholesterolemia. Nutr Metab Cardiovasc Dis (2006) 0.90
Blood pressure variability: an additional target for antihypertensive treatment? Hypertension (2011) 0.89
Association of parathyroid hormone and 25-OH-vitamin D levels with arterial stiffness in postmenopausal women with vitamin D insufficiency. J Atheroscler Thromb (2012) 0.89
Prognostic value of low and high ankle-brachial index in hospitalized medical patients. Eur J Intern Med (2011) 0.89
Second statement of the working group on electrocardiographic diagnosis of left ventricular hypertrophy. J Electrocardiol (2011) 0.88
Operator exposure to x-ray in left and right radial access during percutaneous coronary procedures: OPERA randomised study. Heart (2013) 0.88
Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study. Am J Hypertens (2013) 0.87
Prostaglandin E1 improves endothelial function in critical limb ischemia. J Cardiovasc Pharmacol (2003) 0.86
Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin. Br J Haematol (2007) 0.85
A 32-year-old woman with breast swelling and crepitant rales. CMAJ (2004) 0.85
Increased short-term blood pressure variability is associated with early left ventricular systolic dysfunction in newly diagnosed untreated hypertensive patients. J Hypertens (2013) 0.84
Mechanisms of high-density lipoprotein cholesterol effects on the endothelial function in hyperlipemia. Metabolism (2003) 0.84
Assessing cardiovascular risk: should we discard diastolic blood pressure? Circulation (2009) 0.84
Association of body mass index with arterial stiffness and blood pressure components: a twin study. Atherosclerosis (2013) 0.83
Attenuation of inflammation with short-term dietary intervention is associated with a reduction of arterial stiffness in subjects with hypercholesterolaemia. Eur J Cardiovasc Prev Rehabil (2004) 0.83
Metabolic syndrome and preclinical atherosclerosis: focus on femoral arteries. Metabolism (2007) 0.83
Progression of renal artery stenosis after renal denervation. Impact on 24-hour blood pressure. Circ J (2013) 0.83
Determinants of blood pressure variability in youth: at the roots of hypertension. J Hypertens (2010) 0.82
Metabolic syndrome: at the crossroads of cardiorenal risk. J Nephrol (2009) 0.82
Idiopathic, serial coronary vessels dissection in a young woman with psychological stress: a case report and review of the literature. Case Rep Vasc Med (2012) 0.82
Impact of primary PCI volume on hospital mortality in STEMI patients: does time-to-presentation matter? J Thromb Thrombolysis (2011) 0.82
Antihypertensive drug treatment and circadian blood pressure rhythm: a review of the role of chronotherapy in hypertension. Curr Pharm Des (2015) 0.81
Evidence for a strong genetic influence on carotid plaque characteristics: an international twin study. Stroke (2012) 0.81
Left ventricular hypertrophy reversal and prevention of diabetes: two birds with one stone? Hypertension (2007) 0.80
Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function. J Cardiovasc Pharmacol Ther (2009) 0.80
Carotid-femoral pulse wave velocity assessment using novel cuff-based techniques: comparison with tonometric measurement. J Hypertens (2013) 0.80
Cardiovascular risk factors and recommended lipid goals attainment among patients referred in a tertiary care lipid clinic. Eur J Intern Med (2011) 0.80
Negative influence of HIV infection on day-night blood pressure variability. J Acquir Immune Defic Syndr (2010) 0.80
Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30. J Rheumatol (2007) 0.80
Time course changes of cystatin C and inflammatory and biochemical markers in non-ST-elevation acute coronary syndromes. J Cardiovasc Med (Hagerstown) (2014) 0.79
Plasma C-reactive protein in subjects with hypo/hyperalphalipoproteinemias. Metabolism (2003) 0.79
Acute renal failure and metabolic alkalosis in a patient with colorectal villous adenoma (McKittrick-Wheelock syndrome). Surgery (2012) 0.79
Obstructive Sleep Apnea and Cardiovascular Disease - A New Target for Treatment. Curr Pharm Des (2015) 0.79
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study. J Hypertens (2017) 0.78
Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement. J Cardiovasc Med (Hagerstown) (2006) 0.78
Central and 24-h blood pressure: dwarfs standing upon the shoulders of giants? J Hypertens (2011) 0.78
From hypertension to hypertrophy to heart failure: the role of cardiotrophin-1. J Hypertens (2013) 0.78
Direct association between high-density lipoprotein cholesterol and endothelial function in hyperlipemia. Am J Cardiol (2002) 0.78
Cervical spondylodiscitis with spinal epidural abscess caused by Aggregatibacter aphrophilus. J Med Microbiol (2008) 0.78
Different roles for anti-cyclic citrullinated peptide antibodies and CD4+CD28null cells in the acceleration of atherosclerosis in rheumatoid arthritis: comment on the article by Farragher et al. Arthritis Rheum (2009) 0.77
Pharmacogenomics of left ventricular hypertrophy reversal: beyond the 'one size fits all' approach to antihypertensive therapy. J Hypertens (2004) 0.77
Hypertrophy at ECG and its regression during treatment survey (HEART survey). Rationale, design and baseline characteristics of patients. Ital Heart J (2003) 0.77
D-dimer and duration of anticoagulation. N Engl J Med (2007) 0.77
An endogenous brake on the sympathetic nervous system: the emerging role of catestatin in hypertension. J Cardiovasc Med (Hagerstown) (2011) 0.77
Estimate of white-coat effect and arterial stiffness. J Hypertens (2007) 0.76
Interactions between thrombophilic genetic mutations and clinical bleeding in patients on chronic oral anticoagulant treatment. Haematologica (2005) 0.76
Importance and limits of pre-hospital electrocardiogram in patients with ST elevation myocardial infarction undergoing percutaneous coronary angioplasty. Eur J Cardiovasc Prev Rehabil (2011) 0.76
Right ventricular hypertrophy in systemic hypertension: an updated review of clinical studies. J Hypertens (2013) 0.76
Prevalence of antiphospholipid and antioxidized low-density lipoprotein antibodies in rheumatoid arthritis. Ann N Y Acad Sci (2005) 0.76
Response to are observational studies more informative than randomized controlled trials in hypertension? Pro side of the argument. Hypertension (2013) 0.75
Hypertension in HIV patients. AIDS (2006) 0.75
What are the real determinants of the ambulatory arterial stiffness index? J Hypertens (2012) 0.75
Treating hypertensive non-dippers: additional benefit from nocturnal blood pressure reduction? Cardiovasc Drugs Ther (2005) 0.75
On-treatment C-reactive protein and HDL cholesterol levels in patients at intermediate cardiovascular risk: impact on carotid intima-media thickness. Life Sci (2013) 0.75
Twenty-four-hour ambulatory central blood pressure: new perspectives for blood pressure measurement? J Hypertens (2014) 0.75
The difficult art of detecting left ventricular hypertrophy in obesity: not all ECG criteria are created equal. J Hypertens (2013) 0.75
Aerobic physical exercise and arterial de-stiffening: a recipe for vascular rejuvenation? Hypertens Res (2012) 0.75
Road accident due to a pancreatic insulinoma: a case report. Medicine (Baltimore) (2015) 0.75
Long-term weight loss and blood pressure reduction: the perfect is the enemy of the good. Am J Hypertens (2006) 0.75
Genetic influence on the relation between exhaled nitric oxide and pulse wave reflection. J Breath Res (2013) 0.75
Hypoadiponectinemia: a novel link between obesity and hypertension? Hypertension (2007) 0.75
Irbesartan for heart failure with preserved ejection fraction. N Engl J Med (2009) 0.75
Pulmonary venous flow in hypertension: ready for prime time? J Hypertens (2008) 0.75
The emerging role of atherosclerotic cardiovascular disease in systemic lupus erythematosus. Nutr Metab Cardiovasc Dis (2009) 0.75
Genetic and environmental factors on the relation of lung function and arterial stiffness. Respir Med (2013) 0.75
Antihypertensive treatment and left ventricular mass reduction: the importance of choosing the comparator. Hypertension (2009) 0.75
Uncertainties in estimating the site of arterial wave reflection. Hypertension (2008) 0.75
Assessing vascular benefits of tetrahydrobiopterin supplementation: does analytical method matter? Am J Hypertens (2013) 0.75
Obstructive sleep apnea and reverse dipping: the bad companions. J Hypertens (2014) 0.75
Determinants of the ambulatory arterial stiffness index regression line. Hypertension (2009) 0.75
Central blood pressure: getting to the heart of the matter. J Hypertens (2010) 0.75
Serum triglyceride concentration and coronary heart disease. Circulation (2002) 0.75